Crocs, Inc. vs TransMedics Group Inc — how do they compare? Crocs, Inc. trades at $131.61 (market cap $6.31B), while TransMedics Group Inc trades at $89.69 (market cap $3.10B). The key difference: Crocs, Inc. is far larger — about 2× TransMedics Group Inc's market cap, and Crocs, Inc. is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| CROX | TMDX | |
|---|---|---|
Market Cap | $6.31B | $3.10B |
Sector | Consumer Staples | Technology |
52-Week High | $141.19 | $150.42 |
52-Week Low | $73.39 | $61.99 |
Enterprise Value | $7.83B | $3.49B |
Trailing returns across standard periods
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →